Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
Immunotherapy
LeukemiaLeukemiaLeukemia
Lung CancerLung Cancer
LymphomaLymphomaLymphomaLymphomaLymphoma
Myeloma
Rare CancersRare CancersRare CancersRare Cancers
Sarcoma
Skin CancerSkin Cancer
Thyroid Cancer
    • Subscribe
Advertisement

Article

November 1, 2021

Nighttime Compression Demonstrates ‘Amazing Results’ for Patients With Breast Cancer-Related Lymphedema

Author(s):

Colleen Moretti

Lymphedema can cause swelling, discomfort and body image issues for patients with breast cancer, but nighttime compression may help reduce the effects of the complication.

Wearing a compression bandage or compression system garment at night may improve arm lymphedema in patients with breast cancer, according to study results.

Lymphedema, which occurs in 21% of women, is swelling that occurs in the arm on the side that a patient underwent surgery for breast cancer. Margaret L. McNeely, physical therapist and professor at the University of Alberta in Canada, explained in an interview with CURE® that lymphedema can be progressive in some patients, which means it can worsen over time, causing discomfort, and increasing the risk of infection or cellulitis in the arm.

McNeely, who was lead author of the study, added that it can impede on a patient’s daily functions because the arm can become so swollen and that some women have trouble finding clothes that fit them correctly. It can also cause body image issues; she said some women describe it as having arms that don’t match ­— as if having one arm from someone else’s body.

“There’s that aspect of (lymphedema) that it’s always there and it’s a constant reminder that they had cancer. Unfortunately, it’s a chronic condition that never goes away,” McNeely added.

She and other researchers sought to discover how to alleviate this discomfort and reduce lymphedema swelling in patients with breast cancer. Their study, which was published in the journal Cancer, evaluated 120 women who were split into three groups: standard care (daytime use of a compression sleeve alone; 39 patients), standard care plus multilayered compression bandaging at night (44 patients) and standard care plus nighttime compression system garments (37 patients).

At the end of the study period, 118 patients competed the trial and 114 completed the 24-week follow up.

Results demonstrated that wearing compression at night, whether it be compression bandaging or a compression system garment, was more effective than only wearing compression during the day. McNeely explained that for some individuals the arm swells more during the night, so the compression can help to treat the lymphedema as they sleep. For others, the compression provides a means to support the lymphatic system, so that more fluid is removed when the individuals is resting. This allows the system to ‘catch up’ a bit at night.

“Especially for the women who had the milder versions of lymphedema, we saw some amazing results,” she added.

McNeely mentioned that the improvement in swelling is subtle, so it takes longer to see, but those women enrolled in the trial who did see benefit were very thankful. She added that for many of the women, over time, the garment became so comfortable for them to wear at night that they often felt uncomfortable if they didn’t wear it when sleeping. Many felt it was very easy to apply and more comfortable to wear than a daytime garment.

Interestingly, quality of life was improved across all three groups, which McNeely said “was a bit of a surprise” to her and the other researchers. “We had anticipated we would see more improvement in quality of life in the groups that had the nighttime compression, but we saw an improvement across all groups, which ended up then not being statistically significant.”

They hypothesized that this might have been because often adherence to daytime compression is poor, but in this study, it was “excellent,” so even those wearing only daytime compression some saw a slight improvement in their condition.

McNeely concluded that earlier introduction to nighttime compression may benefit women.

“We need to change our approach so that we actually introduce nighttime compression earlier when the arm swelling is less severe. In these early cases, we may be able to reduce the swelling to a subclinical level, where you can barely see the swelling.” In that way, McNeely said that earlier use of compression for these patients may help them better control the condition in the long run.

“(When we introduce) it earlier, we don’t keep the woman on the same pathway that’s allowing their condition to slowly get worse, or to fluctuate, that kind of arthritis-type pattern where it flares up, and then it settles, then it flares up again. “If we can keep the swelling nicely in control, and keep the limb healthy, the individual may be better able to take part in other activities that will further benefit their lymphedema and overall wellness, such as exercising.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of woman.
Image of Doctor.
Related Content
Advertisement
Image of Patti.
June 12th 2025

Beyond Treatment: How Support Groups Helped Me Embrace My New Normal

Patti McGee
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Dr. Mabel Mardones educates patients on breast cancer updates: © stock.adobe.com.
June 10th 2025

Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions

Kristie L. Kahl
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
June 4th 2025

Dealing with Insensitivity After Breast Cancer Surgery

Bonnie Annis
Breast cancer surgery can disfigure the body in some way, and often the scars are more than skin deep, which may worsen by the actions of others.
Image of two woman.
June 3rd 2025

Kisqali Benefit Lasts Across Age in Breast Cancer Subset

Gina Mauro
Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, HER2-negative breast cancer.
Related Content
Advertisement
Image of Patti.
June 12th 2025

Beyond Treatment: How Support Groups Helped Me Embrace My New Normal

Patti McGee
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Dr. Mabel Mardones educates patients on breast cancer updates: © stock.adobe.com.
June 10th 2025

Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions

Kristie L. Kahl
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
June 4th 2025

Dealing with Insensitivity After Breast Cancer Surgery

Bonnie Annis
Breast cancer surgery can disfigure the body in some way, and often the scars are more than skin deep, which may worsen by the actions of others.
Image of two woman.
June 3rd 2025

Kisqali Benefit Lasts Across Age in Breast Cancer Subset

Gina Mauro
Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, HER2-negative breast cancer.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.